
PYXS Valuation
Pyxis Oncology Inc
- Overview
- Forecast
- Valuation
- Earnings
PYXS Relative Valuation
PYXS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PYXS is overvalued; if below, it's undervalued.
Historical Valuation
Pyxis Oncology Inc (PYXS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.91. The fair price of Pyxis Oncology Inc (PYXS) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:1.13
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.68
P/B
Median3y
0.78
Median5y
0.69
-82.09
FCF Yield
Median3y
-83.65
Median5y
-72.74
Competitors Valuation Multiple
The average P/S ratio for PYXS's competitors is 476.34, providing a benchmark for relative valuation. Pyxis Oncology Inc Corp (PYXS) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

MNDY
monday.com Ltd
291.800
USD
+0.68%

MYO
Myomo Inc
1.990
USD
-2.93%

FSK
FS KKR Capital Corp
22.370
USD
-0.49%

PTON
Peloton Interactive Inc
6.290
USD
+0.16%

ENVX
Enovix Corp
15.540
USD
-2.45%

OCGN
Ocugen Inc
1.020
USD
+2.00%

LYFT
Lyft Inc
14.760
USD
0.00%

IDXX
IDEXX Laboratories Inc
514.610
USD
-0.79%

QS
Quantumscape Corp
14.640
USD
+7.65%

TTD
Trade Desk Inc
80.210
USD
-1.51%
FAQ

Is Pyxis Oncology Inc (PYXS) currently overvalued or undervalued?
Pyxis Oncology Inc (PYXS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.91. The fair price of Pyxis Oncology Inc (PYXS) is between NaN to NaN according to relative valuation methord.

What is Pyxis Oncology Inc (PYXS) fair value?

How does PYXS's valuation metrics compare to the industry average?

What is the current P/B ratio for Pyxis Oncology Inc (PYXS) as of Jul 20 2025?

What is the current FCF Yield for Pyxis Oncology Inc (PYXS) as of Jul 20 2025?

What is the current Forward P/E ratio for Pyxis Oncology Inc (PYXS) as of Jul 20 2025?
